to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.